Floatz logo

Mtm-H-001

Myasthenia Gravis (MG)

Beijing GoBroad HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Myasthenia Gravis (MG) cohort.

Asset / SponsorPhaseRating
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
Evomela
Fred Hutchinson Cancer Center
Phase 2CCC
PREDNISONE TABLETS
Fred Hutchinson Cancer Center
Phase 2CCC
CARMUSTINE
Fred Hutchinson Cancer Center
Phase 2CCC
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 2CCC

View all 22 →

Same molecule, other indications

Mtm-H-001 is also rated in:

follicular lymphomaDormant
D
Indicative ·
30 / 100
View asset →
mantle cell lymphomaDormant
D
Indicative ·
30 / 100
View asset →
diffuse large B-cell lymphomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →